FDA slows down on drug reviews, approvals amid Trump admin chaos
NegativeTechnology

The FDA has hit the brakes on drug reviews and approvals due to the ongoing chaos of the Trump administration, which has also led to a halt in accepting new drug submissions. This slowdown is concerning as it could delay access to potentially life-saving medications for patients who rely on timely approvals for new treatments.
— Curated by the World Pulse Now AI Editorial System